Zogenix Says CFO Ann Rhoads Departs

Zogenix, a pharmaceutical company, said that due to the company’s ongoing relocation of all corporate functions, including finance, from San Diego, CA, to Emeryville, CA, chief financial officer Ann Rhoads will depart Zogenix following a transition period.

Michael Smith, most recently CFO at Raptor Pharmaceutical, has been appointed to fill the position, effective Jan. 16. Rhoads will continue to serve as Zogenix’s CFO through Jan. 16, and thereafter has agreed to provide consulting services to the company in connection with the transition of duties to Smith, the completion of the 2016 year-end audit and related filings for the year ended Dec. 31, 2016.

Smith has over 18 years of experience in senior executive roles at publicly-traded and private biotechnology companies.

Leave a Comment